– USA, MA – 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, announced the appointment of Michele Leonhart to its Board of Directors effective immediately, bringing a deep understanding of our customers in law enforcement and adjacent markets.
“I am delighted to welcome Michele to 908 Devices’ Board of Directors. Michele brings extensive government knowledge and experience on drug interdiction, from local to federal levels, and importantly, is a passionate advocate for the prevention of substance abuse in children and young adults,” said Board Chairman, Kevin Hrusovsky.
About Michele M. Leonhart
Her 34-year career in the DEA encompassed various positions with increasing levels of responsibility, including Special Agent in Charge of the Los Angeles Field Division from 1998 to 2003, Deputy Administrator from 2003 to 2007, Acting Administrator from 2007 to 2010, and Administrator from 2010 to 2015. As the highest-ranking executive in the DEA from 2007 to 2015, Ms. Leonhart was responsible for leading the $2.4 billion global drug enforcement, intelligence, laboratory, administrative, and regulatory operations of the agency’s 227 domestic and 86 foreign offices and directed day-to-day operations and oversight of over 9,000 employees. Ms. Leonhart retired from the DEA in 2015 and has served on the Board of Directors of the non-profit D.A.R.E America / D.A.R.E. International since 2015 and as its Board Chair since 2018.
“I am honored to join the Board of Directors for 908 Devices,” said Ms. Leonhart. “I look forward to working with the Company’s talented leadership team as they further their efforts in providing law enforcement personnel with devices that rapidly identify illicit drugs to keep our communities safe.”
About 908 Devices
908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. The Company’s devices are used at the point of need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in bioprocessing, pharma/biopharma, forensics, life sciences research, and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of complementary analytical technologies, microfluidic sampling and separations, software automation, and machine learning.
For more: https://908devices.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.